SCINAI IMMUNOTHERAPEUTICS LTD. (SCNI) Operating cash flow 2021–2025
SCINAI IMMUNOTHERAPEUTICS LTD. (SCNI) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$6.0MFY2025 · since FY2021: -$7.4M → -$6.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$6.0M | +4.8% |
| FY2024 | -$6.3M | +32.5% |
| FY2023 | -$9.4M | -29.1% |
| FY2022 | -$7.3M | +2.2% |
| FY2021 | -$7.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice